Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2018, Article ID 1691474, 7 pages
https://doi.org/10.1155/2018/1691474
Research Article

Association between CD4 Cell Count and Blood Pressure and Its Variation with Body Mass Index Categories in HIV-Infected Patients

1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
2Department of Orthopaedics, Southend University Hospital, Essex, UK
3Health and Human Development (2HD) Research Network, Douala, Cameroon
4Presbyterian General Hospital Acha-Tugi, Acha-Tugi, Cameroon
5Grace Community Health and Development Association (GRACHADA), Kumba, Cameroon
6Department of Vascular Surgery, Ashford and St Peter’s Hospitals NHS, Surrey, UK
7Department of Public Health, Université libre de Bruxelles, Brussels, Belgium
8Diabetes and Endocrinology Unit, Department of Internal Medicine, Douala General Hospital, Douala, Cameroon
9Department of Internal Medicine and Paediatrics, Faculty of Health Sciences, University of Buea, Buea, Cameroon

Correspondence should be addressed to Christian Akem Dimala; ku.ca.mthsl.inmula@1alamid.meka.naitsirhc

Received 25 June 2017; Revised 1 November 2017; Accepted 19 December 2017; Published 22 January 2018

Academic Editor: Daniel Duprez

Copyright © 2018 Christian Akem Dimala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health organization, Joint United Nations Programme on HIV/AIDS. FAst facts about HIV treatment. Geneva; 2009.
  2. J. F. Palella, K. M. Delaney, A. C. Moorman et al., “Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection,” The New England Journal of Medicine, vol. 338, no. 13, pp. 853–860, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. G. V. De Socio, E. Ricci, P. Maggi et al., “Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: The HIV-HY study,” American Journal of Hypertension, vol. 27, no. 2, pp. 222–228, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. I. W. Manner, M. Trøseid, O. Oektedalen, M. Baekken, and I. Os, “Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals,” The Journal of Clinical Hypertension, vol. 15, no. 2, pp. 101–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Ngatchou, D. Lemogoum, P. Ndobo et al., “Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naive HIV+ patients from Cameroon,” Vascular Health and Risk Management, vol. 9, no. 1, pp. 509–516, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. E. Ho and P. Y. Hsue, “Cardiovascular manifestations of HIV infection,” Heart, vol. 95, no. 14, pp. 1193–1202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. I. W. Manner, M. Baekken, D. Kvale et al., “Markers of microbial translocation predict hypertension in HIV-infected individuals,” HIV Medicine, vol. 14, no. 6, pp. 354–361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. F. F. Rönsholt, H. Ullum, T. L. Katzenstein, J. Gerstoft, and S. R. Ostrowski, “Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy,” PLoS ONE, vol. 8, no. 6, Article ID e65182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. Stein and P. Y. Hsue, “Inflammation, immune activation, and CVD risk in individuals with HIV infection,” Journal of the American Medical Association, vol. 308, no. 4, pp. 405-406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Carr, K. Samaras, A. Thorisdottir, G. R. Kaufmann, D. J. Chisholm, and D. A. Cooper, “Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study,” The Lancet, vol. 353, no. 9170, pp. 2093–2099, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Cattelan, M. Trevenzoli, L. Sasset, L. Rinaldi, V. Balasso, and P. Cadrobbi, “Indinavir and systemic hypertension,” AIDS, vol. 15, no. 6, pp. 805–807, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Roka, A. Michimi, and G. Macy, “Associations between hypertension and body mass index and waist circumference in U.S. adults: a comparative analysis by gender,” High Blood Pressure & Cardiovascular Prevention, vol. 22, no. 3, pp. 265–273, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Dua, M. Bhuker, P. Sharma, M. Dhall, and S. Kapoor, “Body mass index relates to blood pressure among adults,” North American Journal of Medical Sciences, vol. 6, no. 2, pp. 89–95, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Tate, A. L. Willig, J. H. Willig et al., “HIV infection and obesity: where did all the wasting go?” Antiviral Therapy, vol. 17, no. 7, pp. 1281–1289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Sharma, S. A. Bynum, M. F. Schneider et al., “Changes in body mass index following haart initiation among HIV-infected women in the women’s interagency HIV study,” Journal of AIDS & Clinical Research, vol. 5, no. 7, pp. 2–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. O. J. Ogunmola, O. Y. Oladosu, and A. M. Olamoyegun, “Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study,” Vascular Health and Risk Management, vol. 10, pp. 129–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Dimala, J. Atashili, J. C. Mbuagbaw, A. Wilfred, and G. L. Monekosso, “Prevalence of hypertension in HIV/AIDS patients on highly active antiretroviral therapy (HAART) compared with HAART-naïve patients at the limbe regional hospital, Cameroon,” PLoS ONE, vol. 11, no. 2, Article ID e0148100, 2016. View at Publisher · View at Google Scholar
  18. O. Khatib and M. El-Guindy, “Clinical guidelines for the management of hypertension,” Tech. Rep., World Health Organisation, Cairo, 2005. View at Google Scholar
  19. J. V. Baker, D. Duprez, J. Rapkin et al., “Untreated HIV infection and large and small artery elasticity,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 1, pp. 25–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Y. Hsue, P. W. Hunt, A. Schnell et al., “Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis,” AIDS, vol. 23, no. 9, pp. 1059–1067, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Schillaci, G. V. L. De Socio, G. Pucci et al., “Aortic stiffness in untreated adult patients with human immunodeficiency virus infection,” Hypertension, vol. 52, no. 2, pp. 308–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Schillaci, G. V. L. De Socio, M. Pirro et al., “Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 11, pp. 2381–2385, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. C. Kaplan, L. A. Kingsley, S. J. Gange et al., “Low CD4+ T cell count as a major atherosclerosis risk factor in HIV-infected women and men,” AIDS, vol. 22, no. 13, pp. 1615–1624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. G. S. Bloomfield, J. W. Hogan, A. Keter et al., “Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya,” PLoS ONE, vol. 6, no. 7, Article ID e22288, 2011. View at Publisher · View at Google Scholar · View at Scopus